Form 4 for URGN UroGen Pharma Ltd.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001437749-25-002688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-04 | 2025-01-31 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +8,000 | 146.4K | +6% | — |
| DM | 2025-02-04 | 2025-01-31 | URGN | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $11.14 | -4,551 | 148.5K | -3% | -$50.7K |
| DM | 2025-02-04 | 2025-01-31 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | $0.00 | -8,000 | 6,667 | -55% | $0 |
| D | 2025-02-04 | 2025-01-31 | URGN | Schoenberg Mark | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-31 | M | A | 3,333 | — | 150,436 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 2 | Common | Ordinary Shares | 2025-01-31 | S | D | 1,896 | $11.14 | 147,103 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 3 | Common | Ordinary Shares | 2025-01-31 | M | A | 3,333 | — | 148,999 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 4 | Common | Ordinary Shares | 2025-01-31 | S | D | 759 | $11.14 | 145,666 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 5 | Common | Ordinary Shares | 2025-01-31 | M | A | 1,334 | — | 146,425 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 6 | Common | Ordinary Shares | 2025-01-31 | S | D | 1,896 | $11.14 | 148,540 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 7 | Derivative | Restricted Stock Units | 2025-01-31 | M | D | 1,334 | $0.00 | 0 | D | — · — to — | 1,334 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. |
| 8 | Derivative | Restricted Stock Units | 2025-01-31 | M | D | 3,333 | $0.00 | 3,334 | D | — · — to — | 3,333 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F4) The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. |
| 9 | Derivative | Restricted Stock Units | 2025-01-31 | M | D | 3,333 | $0.00 | 6,667 | D | — · — to — | 3,333 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F5) The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. |
| 10 | Derivative | Restricted Stock Units | 2025-01-31 | A | A | 20,000 | $0.00 | 20,000 | D | — · — to — | 20,000 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F6) 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028. |